Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

China flag China · Delayed Price · Currency is CNY
32.94
+0.70 (2.17%)
Mar 10, 2026, 3:04 PM CST
28.97%
Market Cap 7.72B
Revenue (ttm) 2.36B
Net Income (ttm) 558.24M
Shares Out 234.33M
EPS (ttm) 2.38
PE Ratio 13.83
Forward PE 13.84
Dividend 2.50 (7.75%)
Ex-Dividend Date Oct 17, 2025
Volume 3,973,689
Average Volume 2,632,264
Open 31.74
Previous Close 32.24
Day's Range 31.74 - 32.94
52-Week Range 25.17 - 36.70
Beta 0.08
RSI 50.55
Earnings Date Apr 24, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and succinate capsules. In addition, it offers information product... [Read more]

Sector Healthcare
Founded 1993
Employees 1,759
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000915
Full Company Profile

Financial Performance

In 2024, Shandong Wit Dyne Health's revenue was 2.13 billion, a decrease of -14.08% compared to the previous year's 2.48 billion. Earnings were 515.59 million, a decrease of -11.90%.

Financial Statements

News

There is no news available yet.